Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicenter, Evaluator-blinded, Randomized, Parallel-Group, Controlled Study of the Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation

NCT05452070 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT05452070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05452070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicenter, Evaluator-blinded, Randomized, Parallel-Group, Controlled Study of the Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
September 2, 2022
Completion date
May 8, 2025
Enrollment
171 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

mid face volume deficit